Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact
Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: C1S

Gene summary for C1S

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

C1S

Gene ID

716

Gene namecomplement C1s
Gene AliasEDSPD2
Cytomap12p13.31
Gene Typeprotein-coding
GO ID

GO:0002250

UniProtAcc

F8WCZ6


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
716C1SAEH-subject2HumanEndometriumAEH5.02e-23-5.13e-01-0.2525
716C1SAEH-subject3HumanEndometriumAEH8.63e-14-4.33e-01-0.2576
716C1SAEH-subject4HumanEndometriumAEH1.15e-09-4.17e-01-0.2657
716C1SAEH-subject5HumanEndometriumAEH1.38e-12-4.86e-01-0.2953
716C1SEEC-subject1HumanEndometriumEEC3.98e-09-4.13e-01-0.2682
716C1SEEC-subject2HumanEndometriumEEC1.12e-08-3.92e-01-0.2607
716C1SEEC-subject3HumanEndometriumEEC1.07e-15-4.68e-01-0.2525
716C1SEEC-subject4HumanEndometriumEEC1.01e-09-4.19e-01-0.2571
716C1SEEC-subject5HumanEndometriumEEC8.69e-18-5.14e-01-0.249
716C1SGSM5276935HumanEndometriumEEC1.38e-30-5.93e-01-0.123
716C1SGSM6177620_NYU_UCEC1_lib1_lib1HumanEndometriumEEC3.99e-22-4.87e-01-0.1869
716C1SGSM6177620_NYU_UCEC1_lib2_lib2HumanEndometriumEEC5.34e-27-5.19e-01-0.1875
716C1SGSM6177620_NYU_UCEC1_lib3_lib3HumanEndometriumEEC4.32e-22-4.66e-01-0.1883
716C1SGSM6177621_NYU_UCEC2_lib1_lib1HumanEndometriumEEC7.67e-31-5.76e-01-0.1934
716C1SGSM6177622_NYU_UCEC3_lib1_lib1HumanEndometriumEEC1.04e-32-5.57e-01-0.1917
716C1SGSM6177622_NYU_UCEC3_lib2_lib2HumanEndometriumEEC7.60e-36-5.59e-01-0.1916
716C1SGSM6177623_NYU_UCEC3_VisHumanEndometriumEEC2.34e-03-1.71e-01-0.1269
716C1SLZE8THumanEsophagusESCC1.22e-071.14e+000.067
716C1SLZE20THumanEsophagusESCC1.31e-02-2.37e-010.0662
716C1SLZE24THumanEsophagusESCC1.50e-04-3.02e-010.0596
Page: 1 2 3 4 5 6 7 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
EndometriumThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AEH: Atypical endometrial hyperplasia
EEC: Endometrioid Cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
ProstateThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.BPH: Benign Prostatic Hyperplasia
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:00090609CervixCCaerobic respiration60/2311189/187231.59e-126.36e-1060
GO:00453339CervixCCcellular respiration66/2311230/187232.07e-115.39e-0966
GO:00060919CervixCCgeneration of precursor metabolites and energy105/2311490/187237.40e-096.61e-07105
GO:00159809CervixCCenergy derivation by oxidation of organic compounds74/2311318/187233.83e-082.53e-0674
GO:00516567CervixCCestablishment of organelle localization76/2311390/187233.17e-055.21e-0476
GO:00161977CervixCCendosomal transport48/2311230/187231.65e-041.97e-0348
GO:00307057CervixCCcytoskeleton-dependent intracellular transport40/2311195/187237.92e-046.99e-0340
GO:00160506CervixCCvesicle organization54/2311300/187232.71e-031.85e-0254
GO:00080886CervixCCaxo-dendritic transport17/231175/187238.87e-034.53e-0217
GO:00182054CervixCCpeptidyl-lysine modification62/2311376/187231.04e-024.97e-0262
GO:0006091ColorectumADgeneration of precursor metabolites and energy209/3918490/187233.17e-286.61e-25209
GO:0009060ColorectumADaerobic respiration108/3918189/187239.14e-281.43e-24108
GO:0045333ColorectumADcellular respiration119/3918230/187233.21e-254.02e-22119
GO:0015980ColorectumADenergy derivation by oxidation of organic compounds143/3918318/187232.78e-222.49e-19143
GO:0016197ColorectumADendosomal transport90/3918230/187231.88e-101.73e-0890
GO:0051656ColorectumADestablishment of organelle localization131/3918390/187233.00e-092.06e-07131
GO:0016050ColorectumADvesicle organization101/3918300/187231.65e-077.17e-06101
GO:0051650ColorectumADestablishment of vesicle localization57/3918161/187231.47e-053.15e-0457
GO:0051648ColorectumADvesicle localization59/3918177/187237.83e-051.25e-0359
GO:0030705ColorectumADcytoskeleton-dependent intracellular transport60/3918195/187237.56e-047.59e-0360
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa0517126EndometriumAEHCoronavirus disease - COVID-1999/1197232/84655.19e-273.37e-252.47e-2599
hsa05171112EndometriumAEHCoronavirus disease - COVID-1999/1197232/84655.19e-273.37e-252.47e-2599
hsa0517127EndometriumEECCoronavirus disease - COVID-1999/1237232/84657.43e-264.89e-243.65e-2499
hsa0517136EndometriumEECCoronavirus disease - COVID-1999/1237232/84657.43e-264.89e-243.65e-2499
hsa05171211EsophagusESCCCoronavirus disease - COVID-19156/4205232/84653.18e-082.68e-071.37e-07156
hsa051339EsophagusESCCPertussis48/420576/84651.21e-022.77e-021.42e-0248
hsa05171310EsophagusESCCCoronavirus disease - COVID-19156/4205232/84653.18e-082.68e-071.37e-07156
hsa0513314EsophagusESCCPertussis48/420576/84651.21e-022.77e-021.42e-0248
hsa0517114LiverNAFLDCoronavirus disease - COVID-19111/1043232/84651.01e-413.32e-392.67e-39111
hsa04610LiverNAFLDComplement and coagulation cascades35/104386/84652.48e-112.04e-091.64e-0935
hsa0517115LiverNAFLDCoronavirus disease - COVID-19111/1043232/84651.01e-413.32e-392.67e-39111
hsa046101LiverNAFLDComplement and coagulation cascades35/104386/84652.48e-112.04e-091.64e-0935
hsa046102LiverCirrhoticComplement and coagulation cascades48/253086/84654.41e-075.44e-063.35e-0648
hsa046103LiverCirrhoticComplement and coagulation cascades48/253086/84654.41e-075.44e-063.35e-0648
hsa0517142LiverHCCCoronavirus disease - COVID-19167/4020232/84651.50e-144.19e-132.33e-13167
hsa046104LiverHCCComplement and coagulation cascades57/402086/84653.19e-041.45e-038.04e-0457
hsa051332LiverHCCPertussis48/402076/84654.17e-031.27e-027.06e-0348
hsa0517152LiverHCCCoronavirus disease - COVID-19167/4020232/84651.50e-144.19e-132.33e-13167
hsa046105LiverHCCComplement and coagulation cascades57/402086/84653.19e-041.45e-038.04e-0457
hsa051333LiverHCCPertussis48/402076/84654.17e-031.27e-027.06e-0348
Page: 1 2 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
C1SSNVMissense_Mutationc.1204C>Gp.His402Aspp.H402DP09871protein_codingtolerated(0.09)benign(0.007)TCGA-B6-A0RT-01Breastbreast invasive carcinomaFemale<65III/IVUnknownUnknownSD
C1SinsertionIn_Frame_Insnovelc.387_388insCGCCGCACCACCAAAGAAGGTGCTTGTGTTTGTCAGACAAATp.Ala129_Thr130insArgArgThrThrLysGluGlyAlaCysValCysGlnThrAsnp.A129_T130insRRTTKEGACVCQTNP09871protein_codingTCGA-A2-A0CP-01Breastbreast invasive carcinomaFemale<65I/IIChemotherapycytoxanSD
C1SdeletionFrame_Shift_Delnovelc.153delNp.Leu52SerfsTer21p.L52Sfs*21P09871protein_codingTCGA-EW-A2FV-01Breastbreast invasive carcinomaFemale<65III/IVChemotherapydocetaxelSD
C1SSNVMissense_Mutationnovelc.1810N>Gp.Thr604Alap.T604AP09871protein_codingtolerated(0.61)benign(0.003)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
C1SSNVMissense_Mutationnovelc.1710N>Tp.Trp570Cysp.W570CP09871protein_codingdeleterious(0)probably_damaging(1)TCGA-BI-A0VS-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
C1SSNVMissense_Mutationrs782226018c.362C>Tp.Thr121Metp.T121MP09871protein_codingdeleterious(0)probably_damaging(0.996)TCGA-C5-A1MJ-01Cervixcervical & endocervical cancerFemale<65I/IIUnknownUnknownSD
C1SSNVMissense_Mutationc.527G>Tp.Ser176Ilep.S176IP09871protein_codingdeleterious(0)probably_damaging(0.971)TCGA-A6-2679-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
C1SSNVMissense_Mutationrs781887755c.1447C>Tp.Pro483Serp.P483SP09871protein_codingtolerated(0.15)benign(0.18)TCGA-AZ-6598-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
C1SSNVMissense_Mutationnovelc.80N>Cp.Asn27Thrp.N27TP09871protein_codingdeleterious(0.01)possibly_damaging(0.816)TCGA-CA-6717-01Colorectumcolon adenocarcinomaMale<65I/IIChemotherapyoxaliplatinCR
C1SSNVMissense_Mutationrs781845594c.1327N>Ap.Asp443Asnp.D443NP09871protein_codingtolerated(0.55)benign(0.025)TCGA-DM-A1D0-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
Page: 1 2 3 4 5 6 7 8 9 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
716C1SENZYME, PROTEASE, DRUGGABLE GENOMETNT009
716C1SENZYME, PROTEASE, DRUGGABLE GENOMEinhibitor252166820
716C1SENZYME, PROTEASE, DRUGGABLE GENOMECinryzeCINRYZE
716C1SENZYME, PROTEASE, DRUGGABLE GENOMETS01
716C1SENZYME, PROTEASE, DRUGGABLE GENOMEANX005
716C1SENZYME, PROTEASE, DRUGGABLE GENOMEantibody354702279SUTIMLIMAB
716C1SENZYME, PROTEASE, DRUGGABLE GENOMESHP616
716C1SENZYME, PROTEASE, DRUGGABLE GENOMEMBL10878362
716C1SENZYME, PROTEASE, DRUGGABLE GENOMEANTITHROMBIN
Page: 1